Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/19/15 → 09/8/18 |
Funding
- Ansun BioPharma: $27,799.00
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects with Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
Project: Research